Recently, TRAF3IP2 has been investigated in relation to TNF-i response, as well as in psoriasis and PsA patients, by Ovejero-Benito et al., who reported no significant association between polymorphisms located on this gene and response to anti-TNF drugs [10]. The gene discussed is TRAF3IP2; the disease is psoriasis.